Pathfinders in Biopharma
Subscribe in ParasocialFree on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
Also on
Recent episodes
- What's driving biotech's latest rally?
- Dyne Therapeutics pioneers direct drug delivery to muscle and CNS
- How it feels in the eye of an M&A bidding war
- Why the MFN price battle is heading for court, not legislature
- 4DMT targets global retina market with long-lasting genetic treatment
- Big-value deals set the pace in healthcare M&A
- Is this finally the breakthrough moment for psychedelic therapies?
- No biotech bubble – but can the sector’s rally persist through 2026?
- MindMed: Rethinking brain health with psychedelic therapy
- Funding the future of retinal health with Eyepoint